NeuroPace (NPCE) Inventory (2020 - 2026)

NeuroPace has reported Inventory for 7 years, with the latest figure at $18.1 million in Q2 2026.

• On a quarterly basis, Inventory rose 10.8% year-over-year to $18.1 million in Q2 2026; TTM through Jun 2026 was $18.1 million, a 10.8% increase from a year earlier, with the FY2025 full-year figure at $14.9 million, up 11.07% from the prior year.
• Inventory was $18.1 million for Q2 2026 at NeuroPace, up from $16.7 million in the prior quarter.
• The five-year high for Inventory was $18.1 million in Q3 2025, with the low at $8.1 million in Q1 2022.
• Average Inventory over 5 years is $12.4 million, with a median of $11.4 million recorded in 2024.
• The sharpest annual moves came in 2024 and 2025: Inventory grew 6.2% in 2024, then jumped 50.07% in 2025.
• Over 5 years, Inventory stood at $9.7 million in 2022, then advanced by 15.47% to $11.2 million in 2023, then rose by 19.32% to $13.4 million in 2024, then increased by 11.07% to $14.9 million in 2025, then grew by 21.86% to $18.1 million in 2026.
• The last three Inventory figures came in at $18.1 million (Q2 2026), $16.7 million (Q1 2026), and $14.9 million (Q4 2025), per Business Quant data.